U.S. Markets close in 4 hrs 46 mins

Strategic Rationale behind Alexion’s Acquisition

Sarah Collins
Strategic Rationale behind Alexion’s Acquisition

Wilson Therapeutics is a biopharmaceutical company focused on developing rare disease therapies. The company is listed on the Nasdaq Stockholm Exchange and has a market capitalization of 6.5 billion Swedish kronor. Wilson Therapeutics is developing a novel therapy to treat Wilson disease, which is a rare genetic and chronic disorder characterized by an accumulation of copper in the brain, liver, and other vital organs.